BlueStone Venture Partners is a venture capital firm that teams with inspired entrepreneurs to develop their visions to build industry-leading companies. BlueStone provides strategic capital and support to early-stage life science companies residing in, what we call the “NATO" states (New Mexico, Arizona, Texas & Oklahoma). BlueStone’s focus is in medical devices, health IT, advanced materials and molecular diagnostics. Companies in these states have historically been overlooked by many of the legacy venture capital funds despite the presence of strong research institutions, best-in-class technology, and talented leadership teams. BlueStone has a wide and deep network in the region enabling access to unique and highly attractive deals. BlueStone primarily invests in Series A and Series B equity rounds. As such, we see an opportunity to leverage our experience, invest in outstanding companies with attractive valuations, and drive superior returns for our Limited Partners.
9
Total Investments
6
Portfolio Companies
-
Exits
4
Industries
General Information
Industries
Biotechnology, Financial Services +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BlueStone Venture Partners
Recent Investments (9)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Mar 2023 | |
| Series B | •••••• | Jun 2022 | |
| Series B | •••••• | Oct 2021 | |
| Series A | •••••• | May 2021 | |
| Series B | •••••• | Nov 2020 | |
|
|
Series B | •••••• | May 2020 |
|
|
Series B | •••••• | May 2019 |
|
|
Series A | •••••• | Jan 2019 |
|
|
Series A | •••••• | Oct 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.